DAVID GRANOVSKY

Posts Tagged ‘DOCTOR’

YOUR BRAIN, THE EMPTY CUP

In SCIENCE & STEM CELLS, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on June 4, 2014 at 8:40 am

empty-cup  819px-Complete_neuron_cell_diagram_en.svg

15 years ago, modern science was confronted with the premise that HEART type cells could regenerate, overturning hundreds of years of empirical knowledge including over 400 years of clinical trial results (The first clinical trial of a novel therapy was conducted unintentionally by the Renaissance surgeon Ambroise Parè in 1537).  Ask your doctor if heart cells can regenerate.  There is still ENORMOUS resistance.

10 years ago, modern science was confronted with the premise that BRAIN type cells could regenerate, overturning hundreds of years of empirical knowledge including over 400 years of clinical trial results.  Ask your doctor if brain cells can regenerate.  There is still ENORMOUS resistance.

3 days ago Duke researchers published a study in the peer reviewed journal Nature about how they “found a new type of neuron in the adult brain that is capable of telling stem cells to make more new neurons.”

While this is incredible news, science is still moving too slowly for those suffering from chronic and terminal diseases, dementia, TBI and other neurological disorders.  Is it time to revamp the system?  Is it time to approach healing and science with the premise that the human body has regenerative capabilities and we should tap into those systems to heal disorders instead of treating symptoms far removed from the original disorders?  What other premises are in place which are blocking medical advancements?

A story from Zen Buddhism:
Nan-in served tea. He poured his visitor’s cup full, and then kept on pouring.  The professor watched the overflow until he no longer could restrain himself. “It is overfull. No more will go in!”  “Like this cup,” Nan-in said, “you are full of your own opinions and speculations. How can I show you Zen unless you first empty your cup?”

Regenerative medicine is a new frontier.  Already around for decades, most have yet to recognize it as the huge paradigm shift which necessitates our emptier our cups and approaching medicine from a completely new perspective.  A new perspective which includes an empty cup.

Is your thinking, holding you back?

via
http://www.sciencedaily.com/releases/2014/06/140602102006.htm
http://www.nature.com/neuro/journal/vaop/ncurrent/full/nn.3734.html

Advertisements

CELEB DOCTOR VICKI BELO GETS STEM CELLS

In CELEBRITIES & STEM CELLS on January 20, 2012 at 9:29 am

…if her face looks even more younger and radiates with more glow these days, there’s a more potent elixir for the 55-year-old celebrity doctor, in addition to the daily doses of Hayden that she is taking, to thank for, and it is called stem-cell treatment

Vicki Belo confesses

 

 

THE interview was supposed to last no more than 15 minutes, but Vicki Belo revealed such compelling anecdotes about her lover Hayden Kho and her colorful career that executive producer Giselle Ordinario and director Monti Parungao there and then decided to devote the entire 30-minutes of Cocktales talk show to the celebrity dermatologist.Did you know that Vicki, for instance, had tried to match Hayden with her daughter Cristalle, even setting up a date for the two?

 

But no matter how hard her mother pushed, Cristalle was not smitten by the good-looking doctor, preferring her Lebanese boyfriend instead. As it turned out, it was actually the mother, as we now know, who has the hots on her daughter’s date.

Lest we get ahead of the show, check out the Vicki Belo episode this Sunday, a Christmas Day special, at 9:30 p.m. on AksyonTV. Watch Vicki’s body language when she starts talking about Hayden, especially when asked about the May-December affair.

And if her face looks even more younger and radiates with more glow these days, there’s a more potent elixir for the 55-year-old celebrity doctor, in addition to the daily doses of Hayden that she is taking, to thank for, and it is called stem-cell treatment…

 

read more

IMAGINE THERE WAS A STEM CELL INFORMER

In ALL ARTICLES on January 4, 2012 at 3:27 pm

Imagine there was a scientifically complicated subject which was difficult to understand even if you had all the information.  Imagine it would take you days, weeks, months to educate yourself on the subject.  Imagine the subject had more rampant misinformation published than virtually any other subject published in the last 5 years.  Imagine how long it would take you to assess the reams of conflicting information on the subject.  Imagine the subject was further mired in political and religious controversy.

Imagine there was a guy who spent years researching the subject, the science, the studies, the trials, the results, the protocols, the politics and the religious agendas.  Imagine he had one of the premier education blogs on the subject, lectured on the subject, wrote a book on the subject to promote awareness.  Imagine he worked with some of the world’s experts on the subject, wrote their websites and newsletters and internal communications so the layperson could understand the subject. Imagine this guy had an incredible network reaching out to all corners of the world.

Imagine that guy was willing to share all of his information with you free of charge and free of partiality. Imagine he just wanted you to know what your options were so you could make an educated decision just as he did.  Imagine he could shorten your research time logarithmically, he could get your medical data in front of the top stem cell docs in the world withing hours, he could get you an answer to whether you and your specific condition could be treated today or tomorrow.  Imagine he could introduce you to the Director of the Clinic so you could receive the treatment info, the protocol info, the travel info, the costs and the details.

Filling out the form bit.ly/stemcellsnow allows me to approach the top stem cell docs in the world quickly to see if you, with your specific condition, medical history, etc. are a candidate for treatment at their particular facility.  Your condition and needs determine where is best.

I am merely…a bridge or shortcut to get you to your destination with the minimum amount of confusion, time, effort and expense.

DIABETES and STEM CELL TREATMENTS AVAILABLE

In ALL ARTICLES on October 24, 2011 at 9:15 am

Anyone interested in treatment info with one of the best stem cell diabetes doctors in the world can contact me or fill out this form: 
TREATMENT INFORMATION REQUEST – PATIENT QUESTIONNAIRE

——————————-

Can stem cells cure Diabetes – type 1?

In VICTORIES & SUCCESS STORIES on August 31, 2009 at 12:00 pm

Can stem cells cure Diabetes – type 1? See the results of this one year study of adult stem cell treatment of Diabetes type – 1. C-peptide levels, insulin levels, insulin dosage requirements and HA1c levels.

asc_04

asc_05

asc_06

asc_07

Can stem cells cure Diabetes – type 2?

In VICTORIES & SUCCESS STORIES on August 31, 2009 at 12:12 pm

Can stem cells cure Diabetes – type 2? See the results of this one year study of adult stem cell treatment of Diabetes type – 2.  C-peptide levels, insulin levels, insulin dosage requirements and HA1c levels.

asc_10

asc_11

asc_12

asc_13

DIABETES CLINICAL TRIALS

  • FIRST USE OF CORD BLOOD TO ALTER COURSE OF TYPE 1 DIABETES, June 25, 2007 – (I’ll bet nobody heard of this one!)transfusion of stored, autologous (i.e. the person’s own), umbilical cord blood into a group of children newly diagnosed with type 1 diabetes appears to have reduced their disease severity, possibly re-setting the immune system and slowing the destruction of their insulin-producing cells, according to a report presented today at the American Diabetes Association’s 67th Annual Scientific Sessions. –http://parentsguidecordblood.org/content/media/m_pdf/ADA_T1D_PR-06-25-07.pdf(The ADA in 2007 knew stem cells can treat Diabetes type 1 in children!)
  • Diabetes type 1 stem cell clinical trial – Enrollment 11/2003-4/2008, follow-up until December 2008 – https://repairstemcell.wordpress.com/2009/09/14/type-1-diabetes-stem-cells-clinical-trial/

Images from above are from these articles:

  • Why no diabetes clinical trial s in the US when mice were cured of diabetes type 1 in the 1990’s? –  Weissman, a professor of pathology and developmental biology at Stanford University, states: “Stem cells are rare, self-renewing, and can regenerate body tissues.” He repeatedly expressed frustration that while many of his discoveries seemed to hold remarkable potential for life-saving treatments, commercial or regulatory hurdles have prevented his scientific research from benefiting human beings. One example is, his mid-’90s research on type I diabetes, in which he demonstrated the ability to fully cure type I diabetes in mice using stem cells. Even though the experiments avoided political controversy by using adult/repair stem cells, which do not come from embryos, Weissman ran into a road block when pharmaceutical companies refused to sponsor clinical trials. The therapy went nowhere. “The pharmaceutical companies had put profit over principle, preferring to keep diabetes sufferers dependent on costly insulin than to cure them once and for all.” – https://repairstemcell.wordpress.com/2009/09/13/research-from-90s-cures-type-1-diabetes/

If you or a loved one is interested in receiving FREE information on currently available stem cell treatments for DIABETES, please contact me at dsgrano@gmail.com or for other options, go to: CONTACT ME

FRAUD, STEM CELLS, STANDARDS and FINDING THE RIGHT PATH

In BUSINESS OF STEM CELLS on October 16, 2011 at 11:19 am

This really pisses me off! 500 treatment centers out there and most of them are crap and they tarnish the entire industry!  I don’t know if this guy is a crook or not but this is why I recommend only 9 out of the 500 treatment centers. 

There are only 9 treatment centers that have passed a very rigorous set of standards.  Be careful out there guys! The benefits are huge but the path is windy and full of traps.  I’m happy to help those serious about getting treatment. 

Serious about getting treatment information? 

Fill out this form http://bit.ly/PATIENTQUESTIONNAIRE

Nevada doctor pleads not guilty in stem cell case
A prominent Las Vegas-area pediatrician pleaded not guilty Thursday to federal charges that he and a man who falsely claimed he was a doctor conspired to implant chronically ill patients with stem cells harvested from human placentas.

A lawyer for Dr. Ralph Conti issued a statement saying Conti was cooperating with federal authorities and “believes the facts of the case will unfold in a different fashion.”

Conti, 50, of Henderson, is accused of performing procedures on patients in Las Vegas in 2006 at the direction of Alfred Sapse. The indictment alleges that some patients became infected with unspecified ailments.

Prosecutors say Sapse had no medical license in Nevada or any state but operated a company called StemCell Pharma Inc. in Las Vegas.

The company solicited investors and patients with promises to use abdominal implants of placenta tissue to treat incurable diseases such as multiple sclerosis, cerebral palsy and the degenerative eye disease retinitis pigmentosa.

Sapse, now 85, was indicted in 2010 on 20 mail and wire fraud charges. He has pleaded not guilty. His federal public defender, Richard Boulware, declined to comment Thursday.

The indictment handed up Wednesday replaces the previous one against Sapse and leaves both Conti and Sapse facing 34 fraud and conspiracy charges.

“By misrepresenting his credentials, the nature of his treatment, the source of his `stem cells,’ and the adverse effects suffered by previous patients, defendant Sapse convinced chronically ill patients to undergo experimental implant procedures, many of which were performed by Conti,” the indictment said.

The document chronicles payments of $2,500 for implants and says the scheme reaped more than $1 million. Prosecutors allege that Sapse spent about $700,000 of the money on himself, including gambling sprees at Las Vegas casinos.

U.S. Magistrate Judge Carl Hoffman set trial for March 22. Both men could face decades in prison and millions of dollars in fines if convicted. The government also seeks the forfeiture of almost $914,000 it says is tied to the scheme.

Conti’s lawyer, Stan Hunterton, said outside court that Conti has six offices in the Las Vegas area and that he planned to continue to practice while awaiting trial.

“The matter relates to events that occurred five years ago and is unrelated to the pediatric medical practice he has operated successfully in Las Vegas for more than 20 years,” the statement said.

Prosecutors say Sapse claimed to be a retired physician who studied at the Filatov Institute of Eye Diseases and Tissue Therapy in Odessa, Ukraine.

The indictment alleges he hired Conti, who had no stem cell training, to perform placenta tissue implants on about 34 patients in Las Vegas from February to November 2006.

Prosecutors allege that several patients contracted infections, leading the federal Food and Drug Administration to issue a warning in November 2006 that alleged Sapse failed to properly obtain, store, test and process the placentas, or screen donors and patients.

A spokeswoman for U.S. Attorney Daniel Bogden declined to provide details about the infections, pending trial.

Three months after the FDA letter, Sapse moved his operation to Mexico and enlisted an unnamed physician in Nuevo Progresso who the indictment alleges performed about 100 implant procedures from February 2007 to May 2010.

U.S. Medicare rules seek improved care, lower costs

In OFF THE BEATEN PATH on April 1, 2011 at 1:29 pm
This program will create a financial incentive for doctors to take more interest in a patient’s follow up care, thereby, providing better care.
There are some who say that the entire medical and pharma system is based on making money and not on getting you better.  I guess this proves it.
The promise of “better care for patients” apparently wasn’t enough in order to get this program off the ground…they had to both pay doctors more AND show a savings to the government.
While I applaud the program to increase follow up care, this seems to me like doctors are now going to get paid more to do what they should already be doing (and are doing in other countries).
The USA medical system is ranked 37th in the world by the World Health Organization.
U.S. Medicare rules seek improved care, lower costs | Reuters

A patient waits in the hallway for a room to open up in the emergency room at a hospital in Houston, Texas, July 27, 2009. REUTERS/Jessica Rinaldi
A patient waits in the hallway for a room to open up in the emergency room at a hospital in Houston, Texas, July 27, 2009.

WASHINGTON | Fri Apr 1, 2011 8:41am EDT – By Donna Smith

(Reuters) – U.S. Medicare regulators on Thursday launched a program for doctors to deliver more follow-up care to patients that they predict will save the government as much as $960 million over the next three years while providing better healthcare for the elderly.

The Centers for Medicare and Medicaid Services proposed rules under President Barack Obama’s healthcare overhaul setting out guidelines for doctors and hospitals who form so-called accountable care organizations to deliver Medicare services.

The idea, called coordinated care, is to give primary care physicians a financial incentive to follow up on patients who are sent to the hospital or prescribed a course of treatment.

The traditional pay for service structure provides no such incentives, which take the form of a share of any cost savings.

“We’ve known for a long time that too many Americans fail to get the best care when they walk into a hospital or a doctor’s office,” Health and Human Services Secretary Kathleen Sebelius said in a telephone press conference.

“One in every five Medicare beneficiaries who leaves the hospital is back within 30 days. In many cases it is because they failed to receive the correct follow up care,” she added…

U.S. Medicare rules seek improved care, lower costs | Reuters.

HEART DISEASE AND STEM CELL TREATMENTS NOW!

In VICTORIES & SUCCESS STORIES on February 28, 2011 at 10:34 pm

THERE IS NOW NO EXCUSE FOR YOU TO NOT KNOW ABOUT THE HEALING POWER OF ADULT STEM CELLS!  NOW, EVEN READER’S DIGEST KNOWS THAT STEM CELLS CAN BECOME HEART CELLS AND FIX DAMAGED HEART TISSUE.

  • SURE THIS ARTICLE IGNORES MULTIPLE STUDIES GOING BACK TO EARLY 2000 https://repairstemcell.wordpress.com/heart-disease-treatment/
  • SURE THIS ARTICLE IGNORES THE THOUSANDS OF CONGESTIVE HEART FAILURE PATIENTS WHO HAVE BEEN SUCCESSFULLY TREATED WITH STEM CELLS
  • BUT THEY GET IT, THEY KNOW IT’S REAL AND THEY ARE PUBLICIZING IT IN READER’S DIGEST!

 

For more information about stem cell treatments available now for heart disease, email me at dsgrano@gmail.com or click anywhere on the red text.

For more information and to educate yourself on the available Stem Cell treatments for heart disease and the scientific data proving their safety, efficacy, benefits and success.

  1. TREATMENT of HEART DISEASE with STEM CELLS: EDUCATIONAL OVERVIEW
  2. REPAIR STEM CELLS vs. HEART DISEASE – UNDENIABLE SCIENTIFIC EVIDENCE
  3. HEART DISEASE CLINICAL STUDIES – A BRIEF HISTORY
  4. WHAT IS YOUR NEXT STEP?


Reader’s Digest “reaches more readers with household incomes of $100,000+ than Fortune, The Wall Street Journal, Business Week and Inc. combined. Global editions of Reader’s Digest reach an additional 40 million people in more than 70 countries, with 50 editions in 21 languages. It has a global circulation of 17 million, making it the largest paid circulation magazine in the world. It is also published in braille, digital, audio, and large print.”

Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. – Johns Hopkins University (JHU) – Collexis Research Profiling 3.6

In VICTORIES & SUCCESS STORIES on June 22, 2010 at 6:51 pm

VIDEO DESCRIBING IN LAYMAN’S TERMS:

CLINICAL TRIAL OF GROWING HUMAN HEART TISSUE FROM ADULT CARDIAC STEM CELLShttp://www.youtube.com/watch?v=JiM5OP0WUOk

Scientific Abstract of Clinical Trial below…

– – – – – – –

Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies.

Davis Darryl R; Kizana Eddy; Terrovitis John; Barth Andreas S; Zhang Yiqiang; Smith Rachel Ruckdeschel; Miake Junichiro; Marbán Eduardo (Profiled Author: Marban, Eduardo)

Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA – Journal of molecular and cellular cardiology 2010;49(2):312-21.

Abstract

The adult heart contains reservoirs of progenitor cells that express embryonic and stem cell-related antigens. While these antigenically-purified cells are promising candidates for autologous cell therapy, clinical application is hampered by their limited abundance and tedious isolation methods. Methods that involve an intermediate cardiosphere-forming step have proven successful and are being tested clinically, but it is unclear whether the cardiosphere step is necessary.

Accordingly, we investigated the molecular profile and functional benefit of cells that spontaneously emigrate from cardiac tissue in primary culture. Adult Wistar-Kyoto rat hearts were minced, digested and cultured as separate anatomical regions. Loosely-adherent cells that surround the plated tissue were harvested weekly for a total of five harvests. Genetic lineage tracing demonstrated that a small proportion of the direct outgrowth from cardiac samples originates from myocardial cells.

This outgrowth contains sub-populations of cells expressing embryonic (SSEA-1) and stem cell-related antigens (c-Kit, abcg2) that varied with time in culture but not with the cardiac chamber of origin. This direct outgrowth, and its expanded progeny, underwent marked in vitro angiogenic/cardiogenic differentiation and cytokine secretion (IGF-1, VGEF).

In vivo effects included long-term functional benefits as gauged by MRI following cell injection in a rat model of myocardial infarction. Outgrowth cells afforded equivalent functional benefits to cardiosphere-derived cells, which require more processing steps to manufacture. These results provide the basis for a simplified and efficient process to generate autologous cardiac progenitor cells (and mesenchymal supporting cells) to augment clinically-relevant approaches for myocardial repair.

via Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. – Johns Hopkins University (JHU) – Collexis Research Profiling 3.6.

“Stem Cell Awareness Seminar” Tampa, FLA. Aug 28, 2010

In STEM CELLS IN THE NEWS on June 22, 2010 at 6:40 pm

“Stem Cell Awareness Seminar”


August 28,2010 1:00pm – 5:00pm
Free Admission – open to the public

SEMINAR FOCUS:

Learn the Truth regarding the differences between embryonic and adult stem cell treatments. Doctors, patients and others will share their knowledge and experiences with you and answer any questions you may have on stem cells.

Regenerative stem cell therapies for diseases, disorders and injuries will be discussed: ALS, Alzheimer’s disease, Ataxia, Autism, Cerebral Palsy, Diabetes, Heart disease, Lupus, Multiple Sclerosis, Muscular Dystrophy, ONH & optic disorders, Parkinson’s disease, Spinal Cord Injury and Stroke patients have shown significant improvements after treatment.

Several doctors will speak about the progress they have noted in their patients. They will share information with you both pre and post stem cell therapies. You will also hear from several stem cell patients who will share their personal experiences and views of this regenerative therapy. You can also read documented case studies of adult stem cell patients.

David Granovsky, author of “The Stem Cell Blog” and the 1st children’s book on stem cells  “Super Stemmys Doris and the Super Cells” will begin the discussions.

We look forward to meeting you!

LOCATION:

Marriott Tampa Airport Hotel
Tampa International Airport
4200 George J. Bean Pkwy.
Tampa, Florida 33607

Hotel Reservations 800-564-3440 , ask for Stem Cell awareness room block or Http://www.marriott.com/hotels/travel/tpaap? group Code= STCSTCA

SIGN UP:

Please RSVP by filling out the following survey:

STEM CELL AWARENESS SEMINAR SIGN UP SHEET/SURVEY

ORGANIZER’S CONTACT INFO:

Carol Petersen
Stem Cell Advocate
Ph: 1-941-235-0088
carolptrsn@msn.com

High doses of antioxidant supplements induce stem cell genetic abnormalities

In SCIENCE & STEM CELLS on May 4, 2010 at 6:18 pm

High doses of antioxidant supplements induce stem cell genetic abnormalities

May 4, 2010

High doses of antioxidant nutritional supplements, such as vitamins C and E, can increase genetic abnormalities in cells, which may predispose supplement-takers to developing cancer, according to a new study from the Cedars-Sinai Heart Institute.

The study, led by Eduardo Marbán, M.D., Ph.D., director of the Cedars-Sinai Heart Institute, was published online today in the medical journal Stem Cells. The study also will appear in the journal’s July printed edition.

Marbán and his team accidentally discovered the danger of excessive antioxidant doses while seeking a way to reduce the genetic abnormalities that occurred naturally when the scientists sought to multiply human cardiac stem cells.

Marbán stressed that the study’s finding applies only to excessive and not to foods that are rich in antioxidants, such as milk, oranges, blueberries and peanuts. In recent years, multiple studies have touted the benefits of foods rich in antioxidants.

“Taking one multivitamin daily is fine, but a lot of people take way too much because they think if a little is good, a lot must be better,” said Marbán, who is also the Mark Siegel Family Professor at Cedars-Sinai. “That is just not the case. If you are taking 10 or 100 times the amount in a daily multivitamin, you may be predisposing your cells to developing cancer, therefore doing yourself more harm than good.”

In laboratories, stem cells are often grown in a Petri dish culture than is composed of 20 percent oxygen, whereas cells growing inside human tissue are exposed to just 3 to 5 percent oxygen. But Marbán’s team of researchers became frustrated because the higher concentration of oxygen in lab-grown stem cells resulted in 9 percent of the cells being rejected because of genetic abnormalities.

“We sought to counter that oxidation problem by adding high doses of antioxidants directly to the cells,” Marbán said. “That’s when we made the serendipitous discovery that there is a danger zone for the cells exposed to antioxidants to develop genetic abnormalities that predispose to cancer.”

Marbán is leading an ongoing, groundbreaking clinical trial in which heart attack patients undergo two minimally-invasive procedures in an effort to repair and re-grow healthy muscle in a heart injured by a heart attack. First, a biopsy of each patient’s own heart tissue is used to grow specialized heart stem cells. About a month later, the multiplied are then injected back into the patient’s heart via a coronary artery.

The two-step procedure was completed on the first patient in June 2009. The results of the trial are expected in early 2011.

Recently, Marbán received a $5.5 million grant from the California Institute for Regenerative Medicine to continue developing cardiac stem cell therapies.

More information: The complete study is available at http://www3.interscience.wiley.com/journal/121640180/issue

Provided by Cedars-Sinai Medical Center

via High doses of antioxidant supplements induce stem cell genetic abnormalities.

%d bloggers like this: